JPRN-UMIN000016655已完成未知
The effect of tolvaptan in heart failure patients with loop diuretic resistance. - The effect of tolvaptan in heart failure patients with loop diuretic resistance.
Tokyo Women's Medical University, Department of Cardiology0 个研究点目标入组 50 人开始时间: 2015年2月27日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. patients with cardiogenic shock or needs catecholamine or mechanical circulation support 2. intubation 3. obvious bleeding or active gastrointestinal ulceration 4. hemodialysis 5. hyperkalemia (6.0mEq/L) 6. hypernatremia (150mEq/L) 7. hypotension (systolic blood pressure <=85mmHg) or symptomatic hypotension 8. patients who cannot declare thirst or cannot drink water 9. hypersensitivity for Tolvaptan or Mozavaptan 10. expectant mother 11. inappropriate patients judged by the physician in charge
研究者
相似试验
已完成
不适用
Efficacy of Tolvaptan in heart failure patients with preserved Ejection fraction: multicenter, RaNdomized, open-label triAL (ETERNAL)Heart Failure with Preserved Ejection Fraction (HFPEF)JPRN-UMIN000011012agoya University Graduate School of Medicine, Department of Cardiology100
已完成
不适用
Effects of tolvaptan in congestive heart failure patients with renal dysfunctiocongestive heart failureJPRN-UMIN000005465Department of cardiology Osaka city university graduate school of medicine200
Enrolling By Invitation
不适用
Efficacy of Tolvaptan in acute heart failure patients with preserved left ventricular ejection fractioacute decompensated heart failureJPRN-UMIN000013727Osaka General Medical Center120
已完成
不适用
Efficacy and Safety of Tolvaptan in Heart Failure Patients with Renal Impairment and Volume Overload Despite the Standard Treatment with Conventional DiureticsHeart FailureJPRN-UMIN000009201Kanagawa Aquaresis Investigators100
招募中
不适用
Efficacy and Safety Evaluation of Tolvaptan in the Treatment of Patients With RHF Caused by PAHRandomized Controlled TrialPulmonary Arterial HypertensionNCT05569655Chinese Pulmonary Vascular Disease Research Group100